NVSTEnvista Holdings CorpHealthcare · Medical - Instruments & Suppliesas of 2026-09-16
Horizon

Issued 2026-09-16 at $24.97 · now $24.97 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, NVST has typically landed between $21.35 and $28.76 — a range of −14.5% to +15.2% from the issuance price $24.97.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,737 overlapping 1 month windows · 2019-09-18 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($24.97) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where NVST has typically landed a month from the 2026-09-16 close of $24.97 — the range is history, not a prediction.

$21.35worst · -14.5%$28.76best · +15.2%
  • now $24.97 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $24.76 (-0.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $23.05–$26.47
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $21.35–$28.76
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,737 windows spanning 2019-09-18 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-18−57.4%−57.4%+0.0%
2020-02-19−57.4%−57.4%+0.0%
2020-02-20−56.8%−56.8%+0.0%
3 best
2020-04-03+46.5%+0.0%+51.2%
2020-03-23+45.8%+0.0%+48.8%
2020-03-19+43.9%−1.2%+46.9%

1,737 overlapping windows · 2019-09-18 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
57%
+4.2%
n=7
Feb
43%
+2.0%
n=7
Mar
57%
−7.3%
n=7
Apr
43%
−0.1%
n=7
May
57%
+0.5%
n=7
Jun
43%
−0.1%
n=7
Jul
71%
+1.9%
n=7
Aug
43%
+1.7%
n=7
Sep
29%
−3.9%
n=7
Oct
57%
−0.6%
n=7
Nov
57%
+2.5%
n=7
Dec
71%
+4.3%
n=7

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$30$192026-08-20: 1 insider sale, $220K — Reis Mischa2026-02-10: 2 insider sales, $290K — Reis Mischa …2025-08-25: 1 insider sale, $324K — Reis Mischa2025-08: 1 open-market sale, $324K2026-02: 2 open-market sales, $290K2026-08: 1 open-market sale, $220K↑ buys↓ salesofficer Reis Mischa — Sale on 2026-08-20, filed 4 days after the tradeofficer Reis Mischa — Sale on 2026-02-10, filed 1 day after the tradeofficer Reis Mischa — Sale on 2026-02-10, filed 1 day after the tradeofficer Reis Mischa — Sale on 2025-08-25, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-20Reis MischaofficerSale8,000 @ $27.50$220K−22.6% of holdingnot yet — horizon still opennot yet — horizon still open27,321Form 4 · filed 4 days after the trade
2026-02-10Reis MischaofficerSale5,634 @ $30.00$169K−14.8% of holding−11.9%−17.0%32,382Form 4 · filed 1 day after the trade
2026-02-10Reis MischaofficerSale4,041 @ $30.00$121K−11.1% of holding−11.9%−17.0%32,382Form 4 · filed 1 day after the trade
2025-08-25Reis MischaofficerSale15,000 @ $21.60$324K−31.7% of holding−5.9%+31.6%32,382Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

101 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-25Hammes Eric D.officerWithheld for tax10,88599,913Form 4
2026-08-25Acurio VeronicaofficerWithheld for tax7,71048,806Form 4
2026-08-25Befidi RobertofficerWithheld for tax5,14745,785Form 4
2026-08-25Nilsson StefanofficerWithheld for tax80461,560Form 4
2026-08-18Hammes Eric D.officerAward / grant47,97047,970Form 4
2026-08-18Keel Paul AdirectorAward / grant159,900159,900Form 4
2026-08-18Keel Paul AdirectorAward / grant179,730551,304Form 4
2026-05-25Keel Paul AdirectorWithheld for tax12,811371,574Form 4
2026-05-19Raskas DanieldirectorAward / grant9,33054,010Form 4
2026-05-19Carruthers WendydirectorAward / grant9,33059,940Form 4
2026-05-19Jain VivekdirectorAward / grant9,33052,945Form 4
2026-05-19Pierce James AndrewdirectorAward / grant9,33018,485Form 4
2026-05-19TSINGOS CHRISTINE AdirectorAward / grant9,33059,930Form 4
2026-05-19Huennekens R ScottdirectorAward / grant12,58582,105Form 4
2026-05-19GALLAHUE KIERANdirectorAward / grant9,33054,010Form 4
2026-02-25Keel Paul AdirectorWithheld for tax11,840335,715Form 4
2026-02-25Kaabi Faez CofficerWithheld for tax4,96445,032Form 4
2026-02-25Nance Mark EofficerWithheld for tax3,36868,577Form 4
2026-02-25Reis MischaofficerWithheld for tax2,97629,406Form 4
2026-02-25Befidi RobertofficerWithheld for tax2,17743,327Form 4
2026-02-25Hammes Eric D.officerWithheld for tax2,04594,743Form 4
2026-02-25Acurio VeronicaofficerWithheld for tax1,41248,911Form 4
2026-02-25Nilsson StefanofficerWithheld for tax18254,759Form 4
2026-02-25Keel Paul AdirectorAward / grant132,885132,885Form 4
2026-02-25Hammes Eric D.officerAward / grant29,22529,225Form 4
2026-02-25Hammes Eric D.officerAward / grant38,04038,040Form 4
2026-02-25Hammes Eric D.officerAward / grant16,055110,798Form 4
2026-02-25Kaabi Faez CofficerAward / grant13,52058,552Form 4
2026-02-25Befidi RobertofficerAward / grant7,60550,932Form 4
2026-02-25Befidi RobertofficerAward / grant13,84513,845Form 4
2026-02-25Befidi RobertofficerAward / grant18,02018,020Form 4
2026-02-25Nilsson StefanofficerAward / grant7,60562,364Form 4
2026-02-25Nilsson StefanofficerAward / grant13,84513,845Form 4
2026-02-25Nilsson StefanofficerAward / grant18,02018,020Form 4
2026-02-25Acurio VeronicaofficerAward / grant7,60556,516Form 4
2026-02-25Acurio VeronicaofficerAward / grant13,84513,845Form 4
2026-02-25Acurio VeronicaofficerAward / grant18,02018,020Form 4
2026-02-25Keel Paul AdirectorAward / grant48,670384,385Form 4
2026-02-25Keel Paul AdirectorAward / grant115,320115,320Form 4
2026-02-25Nance Mark EofficerAward / grant12,67581,252Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.